Abstract
Background and Objectives
This study aimed to determine the prevalence of visuospatial impairment in a nationally representative sample of older adults and identify self- and informant-reported functional measures associated with visuospatial dysfunction.
Methods
We analyzed data from 3496 participants aged ≥65 years in the 2016 Harmonized Cognitive Assessment Protocol (HCAP), a sub-study of the Health and Retirement Study. Visuospatial function was assessed using the Consortium to Establish a Registry for Alzheimer’s Disease constructional praxis and Mini Mental State Examination pentagon copy tasks. Impairment was defined as a factor score >1.5 SDs below expected relative to a robust normative sample. Cognitive status was classified by HCAP as normal, mild cognitive impairment (MCI), or dementia. Logistic regression models examined associations between visuospatial impairment and functional outcomes, adjusting for demographic, health, and general cognitive factors.
Results
Visuospatial impairment was present in 435 participants (11.33%). Among these, 49.85% had MCI, and 39.97% had dementia. Over half of those with MCI and visuospatial impairment had no other cognitive domain affected. Visuospatial impairment was associated with increased odds of self-reported visual difficulty (OR 1.60, 95% CI: 1.20–2.15), difficulty using a map (OR 3.35, 95% CI: 2.35–4.80), and informant-reported navigation difficulties, including getting lost at home (OR 17.30, 95% CI: 8.02–37.31). Associations with driving, map use, and getting lost at home remained significant after adjusting for general cognition.
Discussion and Implications
Visuospatial impairment is common among older adults, frequently occurs in isolation in MCI, and is strongly associated with functional limitations, particularly in navigation and driving.
Keywords: Health and retirement study, Constructional praxis, Mild cognitive impairment, Dementia
Innovation and Translational Significance:
This study shows that visuospatial impairment is a highly prevalent and often isolated cognitive deficit in older adults with mild cognitive impairment. By using nationally representative data and validated neuropsychological tools and linking them to real-world functional limitations such as spatial navigation and driving, it highlights a critical but underrecognized contributor to aging-related disability. These findings support the integration of visuospatial testing into cognitive aging research and inform policy and clinical strategies to enhance safety, independence, and quality of life in older adults.
Background and objectives
Visuospatial impairment occurs when the brain loses its normal ability to analyze visual information to support navigation and promote an understanding of the surrounding environment and its contents.1 It occurs in typical Alzheimer’s disease (AD)2 and can be a prominent feature of non-AD causes of dementia such as dementia with Lewy bodies,3 in which it is enriched in comparison to AD.4,5 Dementia can also present primarily as visuospatial impairment with relative preservation of other cognitive domains, a phenomenon known as the posterior cortical atrophy (PCA) syndrome.6
A variety of measures have been developed to quantify visuospatial impairments. Broadly, these assays capture deficits in orientation (eg, judgment of line orientation7 or object size4), navigation,8 construction,9 or perception (eg, of motion10). Several studies report that landmark-based navigation worsens with advancing age,11,12 highlighting an age-related decline in navigation dependent on medial temporal rather than parietal structures. Visuospatial function may also depend on and interact with other variables. For example, studies have demonstrated sex-based differences in navigation strategies, whereby women may rely more on landmarks and men more on orientation cues.13
Prior to the onset of dementia, visuospatial impairment also occurs in mild cognitive impairment (MCI), a stage defined by measurably reduced function in at least one cognitive domain14 that does not impact activities of daily living.15 MCI is divided into amnestic and non-amnestic subtypes, but most population-based research has focused on memory impairment in MCI.16,17 Isolated visuospatial impairment is relatively understudied in MCI. In 2003, Mapstone et al. reported that the perception of motion was impaired in one-third of older unimpaired adults and in those with MCI, and half of those with dementia diagnoses.10 Similar gradients of visuospatial impairment have been reported in studies exploring constructional praxis9 and simulated navigation tasks.8
Visuospatial dysfunction is a key contributor to functional impairment in individuals living with dementia.18,19 For example, fall risk20,21 and driving safety22,23 have both been linked to visuospatial impairment. Because people typically perceive visuospatial problems as related to vision rather than cognition, visuospatial symptoms are often directed to optometrists and ophthalmologists rather than primary care doctors or neurologists. For example, the average time between symptom onset and diagnosis for people with the PCA syndrome is 3.6 years, and one in six receives treatment for eye disease (eg, cataract surgery, capsulotomy, epiretinal membrane peel) before visuospatial impairment is recognized as the cause of their symptoms.24 Because these symptoms are often not recognized as being due to neurodegenerative disease until other cognitive domains are affected, early visuospatial predominant MCI is likely underrepresented in clinic-based cohorts such as the Alzheimer’s Disease Neuroimaging Initiative. Additional investigation into visuospatial impairment at the early stages of cognitive decline is needed. Until recently, large nationally representative studies such as the Health and Retirement Study (HRS) relied on telephone interviews to assess cognition, which allowed for effective testing of some domains such as verbal memory, but not others such as visuospatial function. In this study, we aimed to estimate the prevalence of visuospatial impairment in a large, nationally representative sample of older adults and identify self- and informant-reported daily functioning measures that are most strongly associated with visuospatial impairment.
Research design and methods
Standard protocol approvals, registrations, and patient consents
This study was determined to be exempt from approval by the University of Pennsylvania Institutional Review Board (IRB) due to the fully deidentified nature of the datasets. The protocols for HRS were previously approved by the University of Michigan IRB. Informed consent was previously obtained at the time of study enrollment and was not separately required for this secondary analysis.
Study population
The HRS is a large, nationally representative longitudinal survey of US adults older than 50.25 Participants have been surveyed biennially since 1992, with the sample replenished in 1998, 2004, 2010, 2016, and 2022, such that over 42 000 people have participated in HRS to date. In 2016, a random sample of HRS participants aged 65 or older at the time of their 2016 core interview (n = 3496) was enrolled in a substudy called Harmonized Cognitive Assessment Protocol (HCAP), which consisted of a series of questionnaires and neuropsychological tests lasting approximately 1 hour.26,27 As part of this study, participants were asked to nominate up to 3 informants, one of whom was also interviewed.
HCAP cognitive measures
The HCAP cognitive testing protocol included several measures of visuospatial function.26 Using the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) constructional praxis copy task, subjects were asked to copy 4 line drawings in order of increasing complexity, with total scores ranging from 0 to 11.28 After approximately 2 minutes, they were asked to draw the shapes from earlier in the interview to the best of their memory, and results were scored using the same criteria. Subjects were also asked to draw intersecting pentagons as part of the Mini Mental State Examination (MMSE). Using these data, standardized factor scores for visuospatial function and other cognitive domains were previously calculated, and normative cutoffs were established. Briefly, this process consisted of selecting a robust normative sample from within HCAP and adjusting test scores within this population for age, sex, education, race, and ethnicity. Next, neuropsychological test scores were calibrated using latent variable models, and the resulting general and domain-specific factor scores were normalized and then standardized with respect to demographic variables. Finally, t scores (which represent the difference between an individual’s actual factor score and their expected score based on demographic variables) were calculated with a mean of 50 and an SD of 10.29 Subjects with t scores of 35 or lower (indicating that they performed >1.5 SDs below their expected score) were considered to have impairment in the respective cognitive domain. Based on diagnostic criteria from the National Institute on Aging and Alzheimer’s Association workgroups, dementia was defined as having impairment in 2 or more cognitive domains plus an informant report of functional impairment.30 People who did not meet the criteria for cognitive impairment in any domain were classified as having no cognitive impairment. People with impairment in only 1 cognitive domain were classified as having MCI unless both the respondent and informant reported no concerns about cognition or function, in which case they were classified as cognitively unimpaired.
HRS-HCAP respondent and informant interview
Informants were asked whether the subject was able to drive or use public transportation alone. As part of the Community Screening Instrument for Dementia, they were also asked if the subject gets lost in the community (such as when finding the post office or friends’ houses) or at home (such as when finding the toilet). The Blessed Dementia Rating Scale assesses a person’s ability to perform activities of daily living and relies on an informant interview with questions regarding a person’s ability to find their way around familiar streets or around the home or familiar indoor environments.31 Finally, the core HRS survey included a question asking subjects about the quality of their eyesight (excellent, very good, good, fair, or poor). We defined self-reported visual difficulty as a rating of fair or poor for overall, distance, or near eyesight.
Statistical analysis
We used descriptive statistics to summarize the characteristics of HCAP participants with and without visuospatial impairment. Because neuropsychological test scores were calibrated and demographically standardized relative to reference norms, raw test scores were not reported. Within each group, we determined the prevalence of normal cognition, MCI, and dementia using existing definitions in HCAP. Logistic regression was used to examine the association between visuospatial impairment and subject- and informant-reported functional abilities, adjusting for age, race/ethnicity, gender, marital status, education, income, smoking, diabetes, hypertension, heart disease, and stroke. To determine whether these associations were specific to visuospatial function rather than markers of general cognitive impairment, we also adjusted for a generalized cognition factor score, which weighted and harmonized tests of orientation, executive function, language, and memory but did not include visuospatial function.30 We used survey design variables provided by HRS (sampling weight, stratum, and primary sampling unit) to account for the complex survey design of HCAP, and variance estimation was performed using the Taylor series linearization. Subjects with missing data (n = 483) were excluded. Two-sided hypothesis testing was conducted with an alpha of 0.05.
Results
There were 3496 participants in the HRS-HCAP cohort, of whom 435 (11.33%) had visuospatial impairment. The characteristics of individuals with and those without visuospatial impairment are summarized in Table 1. Those with visuospatial impairment were more likely to be older, have lower income, and have a history of hypertension, heart disease, and stroke, and they were less likely to be married than those without visuospatial impairment. Of the 435 subjects with visuospatial impairment, 215 (49.85%) were classified as having MCI, and 178 (39.97%) had dementia (Figure 1); the remainder, 42 (10.19%), were classified as normal. Among those with MCI who had visuospatial impairment, over half (n = 106, 52.71%) had visuospatial function as their only affected cognitive domain. The remainder (n = 109, 47.29%) had impairment in at least one other HCAP-defined cognitive domain (orientation, executive function, memory, or language/fluency).
Table 1.
Characteristics of older adults with vs. without visuospatial impairment in the Health and Retirement Study.
| Variable | No visuospatial impairment (n = 3061) | Visuospatial impairment (n = 435) |
|---|---|---|
| Age | 74.3 ± 0.2 | 76.8 ± 0.8 |
| Race/ethnicity | ||
| White/Caucasian | 2423 (86.32%) | 332 (86.52%) |
| Black/African American | 490 (9.38%) | 73 (9.21%) |
| Hispanic/Other | 147 (4.31%) | 30 (4.27%) |
| Gender | ||
| Female | 1832 (55.73%) | 263 (57.61%) |
| Married | 1755 (60.79%) | 216 (50.41%) |
| Education | ||
| Less than upper secondary | 548 (14.57%) | 105 (19.62%) |
| Upper secondary and vocational training | 1787 (57.66%) | 232 (53.69%) |
| Tertiary | 725 (27.77%) | 98 (26.69%) |
| Income | ||
| 1st quartile (lowest) | 735 (20.27%) | 139 (27.69%) |
| 2nd quartile | 768 (22.08%) | 106 (21.80%) |
| 3rd quartile | 771 (25.42%) | 102 (25.72%) |
| 4th quartile (highest) | 787 (32.23%) | 88 (24.79%) |
| Smoking | 1655 (55.77%) | 258 (55.99%) |
| Diabetes | 898 (27.39%) | 149 (27.84%) |
| Hypertension | 2150 (66.58%) | 331 (73.46%) |
| Heart disease | 1017 (30.86%) | 176 (40.14%) |
| Stroke | 346 (10.00%) | 102 (19.35%) |
Figure 1.
Prevalence of visuospatial impairment, HRS-HCAP 2016. HRS-HCAP, Health and Retirement Study-Harmonized Cognitive Assessment Protocol; MCI, mild cognitive impairment. *Other cognitive domains included orientation, executive function, memory, and language/fluency.
In multivariable-adjusted regression models, visuospatial impairment was associated with an increased odds of self-reported visual difficulty (OR 1.60, 95% CI: 1.20-2.15) and difficulty using a map (OR 3.35, 95% CI: 2.35-4.80). Visuospatial impairment was also associated with informant reports of getting lost in the community (OR 3.05, 95% CI: 2.16-4.31), getting lost at home (OR 17.30, 95% CI: 8.02-37.31), difficulty navigating familiar streets (OR 3.10, 95% CI: 2.16-4.45), and difficulty navigating at home (OR 4.14, 95% CI: 2.51-6.82). Visuospatial impairment was also associated with lower odds of driving (OR 0.28, 95% CI: 0.19-0.39) or using public transportation (OR 0.36, 95% CI: 0.28-0.47). After additionally adjusting for general cognition, associations with driving, using a map, and getting lost at home remained statistically significant (Figure 2). Point estimates for all covariates are presented in Supplementary Tables 1-8.
Figure 2.
Associations between visuospatial impairment and perceived difficulty with vision-related tasks.
Discussion and implications
In this study, we examined the prevalence of visuospatial impairment in MCI and dementia in a nationally representative sample of older adults. We found that approximately 1 in 10 older US adults has visuospatial impairment, about half of whom have MCI, and visuospatial impairment is often the only affected cognitive domain in MCI. We also found strong associations between visuospatial impairment and functional impairment across several activities, including navigation by car and public transport. These findings highlight the prevalence and significance of visuospatial impairment in the older adult population.
Previous population-based studies have relied on tests such as the Telephone Interview for Cognitive Status or MMSE to screen for cognitive impairment.32 These tools provide little to no assessment of visuospatial function, and as a result, data on the epidemiology of visuospatial impairment in the general older adult population are limited. Using a combination of the constructional praxis portion of the CERAD battery and the pentagon copy included in MMSE, we found that the prevalence of visuospatial impairment in adults aged 65 and older in the United States was 11.33%, indicating that visuospatial impairment is common and easily overlooked in the general population when using certain screening tools. Of note, estimates of the prevalence of cognitive impairment depend not only on the overall distribution of cognitive function within a population but also on the sensitivity of cognitive tests and the method by which impairment is defined. For example, using only the Block Design task (a test of visuospatial function that correlates moderately with the CERAD constructional praxis33,34), the Sydney Memory and Aging Study found that the prevalence of visuospatial impairment was 4.1%.35 In contrast, a smaller study that utilized more extended screens of visuospatial function identified deficits in approximately one-fifth of subjects with a mean age of 76.10 The estimated prevalence of visuospatial impairment in HRS-HCAP lies in the middle of this range, but while using two tasks in HRS-HCAP is an advantage, this may still underestimate true prevalence given that discrete aspects of visuospatial function may require multiple tests in order to fully capture impairment.36 Standardized batteries like the Visual Object and Space Perception battery37 and self-reporting assessments such as the Colorado Posterior Cortical Questionnaire (CPC-Q)38 could be employed in future work to better capture the spectrum of visuospatial dysfunction by capturing other aspects such as illusory movement, visual tracking, depth perception, and mental rotation.
We also found that half of those with visuospatial impairment met criteria for MCI, of whom half had impairment only in visuospatial function. Estimates of the prevalence of MCI vary widely and are complicated by several factors, including the choice of screening tools and diagnostic criteria.39 Meta-analyses of the global burden of MCI accounting for these differences yield largely concordant estimates of the total MCI burden around 15%-20%,40,41 similar to the published estimate of 22% in this cohort.30 Harmonized analyses of pooled data suggest that non-amnestic MCI may be more common than amnestic MCI.42 In this study, we found a significant burden of non-amnestic MCI attributable solely to visuospatial impairment. As exemplified by the lived experience of people with the PCA syndrome, symptoms of visuospatial impairment are often first reported to optometrists and ophthalmologists rather than primary care doctors or neurologists, potentially lengthening the time to detection of progressive cognitive impairment.24
We identified robust associations between visuospatial impairment and functional difficulties with vision-related tasks. Associations with driving and other forms of self-navigation persisted even after adjusting for general cognitive impairment, indicating that our analysis captured functionally significant visuospatial impairment. We adjusted for several possible confounders, including marital status, cardiovascular comorbidity, and stroke. These factors have previously been reported in relation both with visual impairment43,44 and driving-related injury42 and driving performance,45,46 which motivated their inclusion as model covariates. From a public health and safety perspective, our findings related to driving are especially pertinent. To date, clinically reliable neuropsychological screening tools for the prediction of driving safety during on-road assessment, including those that measure visuospatial function, remain scarce. Our finding that visuospatial impairment associates with informant report of driving ability, even after adjusting for global cognitive decline, suggests that appropriate in-office screening for visuospatial impairment may be useful as a screening tool for driving safety.47
Our study has several limitations. First, while qualitative assessments of vision were made by survey, objective data on visual acuity were lacking, limiting our ability to account for the effect of eye disease on visuospatial test performance. While this is a major limitation, previous studies have shown that reduced visual acuity is not a significant source of differential item functioning on visuospatial tests.48 Assessments of vision-related functioning were also limited, which represents another major limitation. Missing data could also have served as a source of information bias, though the frequency of this was relatively low. Our study did not capture the full spectrum of visuospatial impairment, nor did it capture other visual brain dysfunctions such as simultanagnosia or visual object perception deficits, which can be screened for using other tools such as the CPC-Q.38 Although the study recruited older adults from a nationally representative sample, it was conducted only in the United States, limiting the generalizability of our findings. This is especially important when considering the functional correlates of visuospatial impairment, as activities such as driving may have less importance in other cultural contexts. Finally, given the inherent limitations of a cross-sectional study design, future studies should examine longitudinal healthcare utilization and outcomes associated with visuospatial impairment in the general population.
Supplementary Material
Acknowledgments
The HRS (Health and Retirement Study) is sponsored by the National Institute on Aging (NIA U01AG009740) and is conducted by the University of Michigan. The RAND HRS Longitudinal File is an easy-to-use dataset based on the HRS core data. This file was developed at RAND with funding from the National Institute on Aging and the Social Security Administration. This analysis uses data or information from the Harmonized HRS dataset and Codebook, Version C as of January 2022 developed by the Gateway to Global Aging Data. The development of the Harmonized HRS was funded by the National Institute on Aging (R01 AG030153, RC2 AG036619, 1R03AG043052). For more information, please refer to www.g2aging.org.
Contributor Information
Rogan G Magee, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Yang Li, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Michael J Rovine, Graduate School of Education, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Victoria S Pelak, Departments of Neurology and Ophthalmology, University of Colorado School of Medicine, Denver, Colorado, United States.
Ali G Hamedani, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States; Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Supplementary material
Supplementary material is available at Innovation in Aging online.
Funding
This work was supported by the National Institutes of Health (K23 EY033438 to A.G.H. and UE5 2UE5NS065745 to R.G.M.) and the John and Joanne Hare Fund for Accelerating PCA Research at the University of Colorado School of Medicine to V.S.P. The National Institute on Aging provided funding for the Health and Retirement Study (U01 AG009740) and the Harmonized Cognitive Assessment Protocol (U01 AG058499).
Conflicts of interest
None declared.
Data availability
The Health and Retirement Study and the Harmonized Cognitive Assessment Protocol data are publicly available for download through the Institute for Social Research at the University of Michigan and the Gateway to Global Aging. The analyses presented in this manuscript were not preregistered.
References
- 1. Possin KL. Visual spatial cognition in neurodegenerative disease. Neurocase. 2010;16:466-487. 10.1080/13554791003730600 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Jack CR Jr, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup. Alzheimers Dement. 2024;20:5143-5169. 10.1002/alz.13859 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88-100. 10.1212/wnl.0000000000004058 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Mori E, Shimomura T, Fujimori M, et al. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol. 2000;57:489-493. 10.1001/archneur.57.4.489 [DOI] [PubMed] [Google Scholar]
- 5. Hamilton JM, Salmon DP, Galasko D, et al. Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology. 2008;22:729-737. 10.1037/a0012949 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Crutch SJ, Schott JM, Rabinovici GD, et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017;13:870-884. 10.1016/j.jalz.2017.01.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Ferman TJ, Smith GE, Kantarci K, et al. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology. 2013;81:2032-2038. 10.1212/01.wnl.0000436942.55281.47 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Laczó M, Wiener JM, Kalinova J, et al. Spatial navigation and visuospatial strategies in typical and atypical aging. Brain Sci. 2021;11:1421-1443. 10.3390/brainsci11111421 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Santagata F, Cappa SF, Presta R, et al. Visuospatial impairment in dementia: a new index to improve the clinical diagnosis of Alzheimer’s disease. Aging Clin Exp Res. 2025;37:127. 10.1007/s40520-025-03028-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Mapstone M, Steffenella TM, Duffy CJ. A visuospatial variant of mild cognitive impairment: getting lost between aging and AD. Neurology. 2003;60:802-808. 10.1212/01.WNL.0000049471.76799.DE [DOI] [PubMed] [Google Scholar]
- 11. Gazova I, Laczó J, Rubinova E, et al. Spatial navigation in young versus older adults. Front Aging Neurosci. 2013;5:94. 10.3389/fnagi.2013.00094 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Iaria G, Palermo L, Committeri G, Barton JJS. Age differences in the formation and use of cognitive maps. Behav. Brain Res. 2009;196:187-191. 10.1016/j.bbr.2008.08.040 [DOI] [PubMed] [Google Scholar]
- 13. Bao R, Chang S, Liu R, Wang Y, Guan Y. Research status of visuospatial dysfunction and spatial navigation. Front Aging Neurosci. 2025;17:1609620. 10.3389/fnagi.2025.1609620 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Petersen RC. Mild cognitive impairment. Continuum. 2016;22:404-418. 10.1212/CON.0000000000000313 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Hampel H, Lista S. The rising global tide of cognitive impairment. Nat. Rev. Neurol. 2016;12:131-132. 10.1038/nrneurol.2015.250 [DOI] [PubMed] [Google Scholar]
- 16. Ding X, Yin L, Zhang L, et al. Diabetes accelerates Alzheimer’s disease progression in the first year post mild cognitive impairment diagnosis. Alzheimer’s Dement. 2024;20:4583-4593. 10.1002/alz.13882 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Varatharajah Y, Ramanan VK, Iyer R, et al. Predicting short-term MCI-to-AD progression using imaging, CSF, genetic factors, cognitive resilience, and demographics. Sci. Rep. 2019;9:2235. 10.1038/s41598-019-38793-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Fukui T, Lee E. Visuospatial function is a significant contributor to functional status in patients with Alzheimer’s disease. Am J Alzheimers Dis Other Dement. 2009;24:313-321. 10.1177/1533317509333903 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Perry RJ, Hodges JR. Relationship between functional and neuropsychological performance in early Alzheimer disease. Alzheimer Dis Assoc Disord. 2000;14:1-10. 10.1097/00002093-200001000-00001 [DOI] [PubMed] [Google Scholar]
- 20. Martin K, Thomson R, Blizzard L, Wood A, Garry M, Srikanth V. Visuospatial ability and memory are associated with falls risk in older people: a population-based study. Dement Geriatr Cogn Disord. 2009;27:451-457. 10.1159/000216840 [DOI] [PubMed] [Google Scholar]
- 21. Oki M, Matsumoto M, Yoshikawa Y, et al. Risk factors for falls in patients with Alzheimer disease: a retrospective study of balance, cognition, and visuospatial ability. Dement Geriatr Cogn Dis Extra. 2021;11:58-63. 10.1159/000514285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Anstey KJ, Horswill MS, Wood JM, Hatherly C. The role of cognitive and visual abilities as predictors in the Multifactorial Model of Driving Safety. Accid. Anal. Prev. 2012;45:766-774. 10.1016/j.aap.2011.10.006 [DOI] [PubMed] [Google Scholar]
- 23. Eby DW, Molnar LJ, Kostyniuk LP, et al. The Relationship Between Visual Abilities and Driving Habits Among Older Drivers: A LongROAD Study. AAA Foundation for Traffic Safety; 2018.
- 24. Shir D, Lee N, McCarter SJ, et al. Longitudinal evolution of posterior cortical atrophy: diagnostic delays, overlapping phenotypes, and clinical outcomes. Neurology. 2025;104:e213559. 10.1212/wnl.0000000000213559 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JW, Weir DR. Cohort profile: the Health and Retirement Study (HRS). Int J Epidemiol. 2014;43:576-585. 10.1093/ije/dyu067 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Langa KM, Ryan LH, McCammon RJ, et al. The Health and Retirement Study Harmonized Cognitive Assessment Protocol Project: study design and methods. Neuroepidemiology. 2020;54:64-74. 10.1159/000503004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Weir DR, Institute for Social Research UoM. 2016 Harmonized Cognitive Assessment Protocol (HCAP) Protocol Summary. 2016. https://hdl.handle.net/2027.42/195732
- 28. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology. 1989;39:1159-1165. 10.1212/wnl.39.9.1159 [DOI] [PubMed] [Google Scholar]
- 29. Jones RN, Manly JJ, Langa KM, et al. Factor structure of the Harmonized Cognitive Assessment Protocol neuropsychological battery in the Health and Retirement Study. J Int Neuropsychol Soc. 2024;30:47-55. 10.1017/S135561772300019X [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Manly JJ, Jones RN, Langa KM, et al. Estimating the prevalence of dementia and mild cognitive impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project. JAMA Neurol. 2022;79:1242-1249. 10.1001/jamaneurol.2022.3543 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114:797-811. 10.1192/bjp.114.512.797 [DOI] [PubMed] [Google Scholar]
- 32. De Looze C, Feeney J, Seeher KM, Amuthavalli Thiyagarajan J, Diaz T, Kenny RA. Assessing cognitive function in longitudinal studies of ageing worldwide: some practical considerations. Age Ageing. 2023;52(Supplement_4):iv13-iv25. 10.1093/ageing/afad122 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Moon H, Lee ES, Na S, et al. Discriminative power of Seoul Cognitive Status Test in differentiating subjective cognitive decline, amnestic mild cognitive impairment, and dementia based on CERAD-K standards. Dement Neurocogn Disord. 2024;23:136-145. 10.12779/dnd.2024.23.3.136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Na S, Seo SW, Kim YJ, Yoo H, Lee ES. Correlation analysis between subtest scores of CERAD-K and a newly developed tablet computer-based digital cognitive test (Inbrain CST). Front Aging Neurosci. 2023;15:1178324. 10.3389/fnagi.2023.1178324 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Sachdev PS, Brodaty H, Reppermund S, et al. The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr. 2010;22:1248-1264. 10.1017/S1041610210001067 [DOI] [PubMed] [Google Scholar]
- 36. Pelak VS, Tang-Wai DF, Boeve BF, et al. Consensus recommendations for clinical assessment tools for the diagnosis of posterior cortical atrophy syndrome from the atypical AD PIA of ISTAART. Alzheimers Dement (Amst). 2023;15:e12474. 10.1002/dad2.12474 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Rapport LJ, Millis SR, Bonello PJ. Validation of the Warrington theory of visual processing and the Visual Object and Space Perception Battery. J Clin Exp Neuropsychol. 1998;20:211-220. 10.1076/jcen.20.2.211.1169 [DOI] [PubMed] [Google Scholar]
- 38. Holden SK, Pelak VS, Sooy T, et al. Development of the Colorado Posterior Cortical Questionnaire within an Alzheimer’s disease study cohort. J Clin Exp Neuropsychol. 2022;44:226-236. 10.1080/13803395.2022.2105820 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Casagrande M, Marselli G, Agostini F, Forte G, Favieri F, Guarino A. The complex burden of determining prevalence rates of mild cognitive impairment: a systematic review. Front Psychiatry. 2022;13:960648. 10.3389/fpsyt.2022.960648 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Bai W, Chen P, Cai H, et al. Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies. Age Ageing. 2022;51. 10.1093/ageing/afac173 [DOI] [PubMed] [Google Scholar]
- 41. Song WX, Wu WW, Zhao YY, et al. Evidence from a meta-analysis and systematic review reveals the global prevalence of mild cognitive impairment. Front Aging Neurosci. 2023;15:1227112. 10.3389/fnagi.2023.1227112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Sachdev PS, Lipnicki DM, Kochan NA, et al. The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: The COSMIC collaboration. PLoS One. 2015;10:e0142388. 10.1371/journal.pone.0142388 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Falkenberg HK, Mathisen TS, Ormstad H, Eilertsen G. “Invisible” visual impairments: a qualitative study of stroke survivors experience of vision symptoms, health services and impact of visual impairments. BMC Health Serv Res. 2020;20:302. 10.1186/s12913-020-05176-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Hanna A, Martinez DL, Ahmed IIK, Schlenker MB. Socioeconomic status and visual impairment and ocular disease in Canada. Can J Ophthalmol. 2025; 10.1016/j.jcjo.2025.09.007 [DOI] [PubMed] [Google Scholar]
- 45. Whitlock G, Norton R, Clark T, Jackson R, MacMahon S. Motor vehicle driver injury and marital status: a cohort study with prospective and retrospective driver injuries. Inj Prev. 2004;10:33-36. 10.1136/ip.2003.003020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Babulal GM, Kolady R, Stout SH, Roe CM. A systematic review examining associations between cardiovascular conditions and driving outcomes among older drivers. Geriatrics (Basel). 2020;5:27-36. 10.3390/geriatrics5020027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Johnston BJ, Mackenzie L, O’Donnell JM, Wesson J. Cognitive clinical assessments to predict performance on an on-road assessment: a scoping review. Disabil Rehabil. 2025:1-9. 10.1080/09638288.2025.2512057 [DOI] [PubMed] [Google Scholar]
- 48. Nichols E, Deal JA, Swenor BK, et al. Assessing bias in cognitive testing for older adults with sensory impairment: an analysis of differential item functioning in the Baltimore Longitudinal Study on Aging (BLSA) and the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). J Int Neuropsychol Soc. 2022;28:154-165. 10.1017/S1355617721000400 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The Health and Retirement Study and the Harmonized Cognitive Assessment Protocol data are publicly available for download through the Institute for Social Research at the University of Michigan and the Gateway to Global Aging. The analyses presented in this manuscript were not preregistered.


